An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of Pseudomonas aeruginosa infection. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Piperacillin, tazobactam drug combination, Tazobactam and Piperacillin-. Its PubChem CID is 9918881.
Piperacillin tazobactam
| CAS No | 123683-33-0 |
|---|---|
| Molecular Formula | C33H39N9O12S2 |
| Molecular Weight | 817.9 g/mol |
| Synonyms | (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4λ6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity.
The listed CAS number is 123683-33-0.
The listed molecular formula is C33H39N9O12S2.
The listed molecular weight is 817.9 g/mol.
(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4λ6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.
The source lists Piperacillin, tazobactam drug combination, Tazobactam and Piperacillin-.